EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Multizentrische Studie

Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents

Robert Bissonnette, Jennifer Soung, Adelaide A Hebert, Andrew E Pink, Andreas Pinter, Angela Y Moore, Yuling Shi, Wen-Hui Wang, Darryl P Toth, Megan Miller-Kassamali, Joseph Cafone, Jingzhi Jiang und 4 weitere

New England Journal of Medicine · 06.11.2025 · 393 (18) · 1784-1795

DOI: 10.1056/nejmoa2504187 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 06.11.2025. Verfasst von Robert Bissonnette und 15 weiteren Autor:innen. Beteiligte Einrichtung: Innovaderm Research, Montreal. Hauptthemen laut MEDLINE: Psoriasis, Receptors, Interleukin, Drugs, Investigational, Dermatologic Agents. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Johnson & Johnson.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisReceptors, InterleukinDrugs, InvestigationalDermatologic AgentsAdolescentAdultFemaleHumansMaleMiddle AgedYoung AdultAdministration, OralDouble-Blind MethodSeverity of Illness IndexSignal TransductionPeptidesNasopharyngitisRespiratory Tract InfectionsIncidenceTreatment OutcomeFollow-Up Studies

Substanzen

IL23R protein, humanReceptors, InterleukinDrugs, InvestigationalDermatologic AgentsPeptides

Autor:innen und Institutionen

  • Innovaderm Research, Montreal.
  • Southern California Dermatology, Santa Ana.
  • Harbor-UCLA Medical Center, Torrance, CA.
  • UTHealth McGovern Medical School, Houston.
  • St. John's Institute of Dermatology, Guy's and St. Thomas' NHS Foundation Trust and King's College London, London.
  • Department of Dermatology, University Hospital Frankfurt am Main, Frankfurt am Main, Germany.

Förderung

  • Johnson & Johnson

Zitieren

APA

Bissonnette, R., Soung, J., Hebert, A. A., Pink, A. E., Pinter, A., Moore, A. Y., Shi, Y., Wang, W. H., Toth, D. P., Miller-Kassamali, M., Cafone, J., Jiang, J., Li, S., DeKlotz, C. M. C., Nunes, F., & Lebwohl, M. G. (2025). Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents. New England Journal of Medicine, 393(18), 1784-1795. https://doi.org/10.1056/nejmoa2504187

Vancouver

Bissonnette R, Soung J, Hebert AA, Pink AE, Pinter A, Moore AY, et al. Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents. New England Journal of Medicine. 2025;393(18):1784-1795. doi:10.1056/nejmoa2504187

BibTeX
@article{Bissonnette2025,
  author = {Bissonnette, Robert and Soung, Jennifer and Hebert, Adelaide A and Pink, Andrew E and Pinter, Andreas and Moore, Angela Y and Shi, Yuling and Wang, Wen-Hui and Toth, Darryl P and Miller-Kassamali, Megan and Cafone, Joseph and Jiang, Jingzhi and Li, Shu and DeKlotz, Cynthia M C and Nunes, Fabio and Lebwohl, Mark G},
  title = {Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {393},
  number = {18},
  pages = {1784--1795},
  doi = {10.1056/nejmoa2504187}
}
Kostenlos starten →